Exelixis Inc (EXEL)
Quick ratio
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Cash | US$ in thousands | 262,994 | 501,195 | 647,169 | 319,217 | 266,501 |
Short-term investments | US$ in thousands | 732,308 | 807,273 | 819,905 | 887,319 | 585,742 |
Receivables | US$ in thousands | 237,407 | 214,784 | 282,650 | 160,875 | 119,073 |
Total current liabilities | US$ in thousands | 394,277 | 324,359 | 337,590 | 204,658 | 142,746 |
Quick ratio | 3.13 | 4.70 | 5.18 | 6.68 | 6.80 |
December 31, 2023 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($262,994K
+ $732,308K
+ $237,407K)
÷ $394,277K
= 3.13
The quick ratio, also known as the acid-test ratio, measures a company's ability to meet its short-term obligations with its most liquid assets. A higher quick ratio indicates a stronger ability to cover short-term liabilities.
Exelixis Inc's quick ratio has shown a declining trend over the past five years. In 2019, the quick ratio was at its highest at 6.80, indicating a robust liquidity position. However, the ratio has steadily decreased to 6.68 in 2020, 5.18 in 2021, 4.70 in 2022, and further down to 3.13 in 2023.
A quick ratio above 1.0 is generally considered healthy, as it suggests the company can cover its current liabilities with its liquid assets. Despite the downward trend, Exelixis Inc's quick ratio remains comfortably above 1.0 in all years, indicating a strong ability to meet its short-term obligations with liquid assets.
However, the decreasing trend in the quick ratio may raise some concerns about the company's liquidity management and its ability to maintain a strong liquidity position in the future. Further analysis of the underlying reasons for this trend and additional financial metrics would provide a more comprehensive understanding of Exelixis Inc's overall financial health.
Peer comparison
Dec 31, 2023